Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

AG-636 for the Treatment of Adults with Advanced Lymphoma: Initiation of a Phase 1 Clinical Study

Scott F. Huntington, MD MPH, Avyakta Kallam, MD, Frank G. Basile, MD, Danielle Ulanet, Huansheng Xu, PhD, Feng Yin, PhD, Michelle Mobilia, BS, Michael Cooper, MD, Bijal Shah, MD, John P. Leonard, MD, Gottfried R. von Keudell, MD PhD, Ajay K. Gopal, MD

Blood (2019) 134 (Supplement_1): 1286.

https://doi.org/10.1182/blood-2019-123420

Published: 2019

Journal Articles

Transcriptional Regulation of Coenzyme Q Biosynthesis By TIF1γ Drives Erythropoiesis

Marlies P. Rossmann, MD PhD, Karen Hoi, Victoria Chan, Julie R. Perlin, PhD, Elliott J. Hagedorn, PhD, Brian J. Abraham, PhD, Song Yang, PhD, Lucas B. Sullivan, PhD, Curtis R. Warren, PhD, Sejal Vyas, PhD, Eugenia Custo-Creig, Bilguujin Dorjsuren, Chad Cowan, PhD, Marcia C. Haigis, PhD, Richard A. Young, PhD, Leonard I Zon, MD

Blood (2019) 134 (Supplement_1): 152.

https://doi.org/10.1182/blood-2019-126833

Published: 2019

Journal Articles

Repurposing Leflunomide for Relapsed/Refractory Multiple Myeloma: Final Analysis of a Phase 1 Study

Michael Rosenzweig, Joycelynne Palmer, Ni-Chun Tsai, Ralf Buettner, PhD, Lupe Duarte, Myo Htut, Chatchada Karanes, Nitya Nathwani, MD, Flavia Pichiorri, PhD, Firoozeh Sahebi, Tim Synold, Xiwei Wu, James F Sanchez, Amrita Krishnan, MD, Stephen J Forman, Steven T Rosen

Blood (2018) 132 (Supplement 1): 2007.

https://doi.org/10.1182/blood-2018-99-120042

Published: 2018

Journal Articles

Repurposing Leflunomide for Relapsed/Refractory Multiple Myeloma: A Phase 1 Trial

Michael Rosenzweig, MD, Joycelynne M. Palmer, PhD, Ni-Chun Tsai, MS, Ralf Buettner, PhD, Lupe Duarte, Myo Htut, Chatchada Karanes, Nitya Nathwani, Flavia Pichiorri, PhD, Firoozeh Sahebi, George Somlo, Tim Synold, PhD, Xiwei Wu, PhD, Amrita Krishnan, MD, Stephen J. Forman, MD FACP, Steven T. Rosen, MD

Blood (2017) 130 (Supplement 1): 3144.

https://doi.org/10.1182/blood.V130.Suppl_1.3144.3144

Published: 2017

Journal Articles

Use of Leflunomide for Treatment of Cytomegalovirus Infection in Recipients of Allogeneic Stem Cell Transplant

Anant Gokarn, MD, Anup Toshniwal, MD, Amogh Pathak, MBBS, Sankalp Arora, MBBS, Avinash Bonda, MD DM, Pankaj Dwivedi, MD, Sachin Punatar, MD DM, Vivek Bhat, MD, Sanjay Biswas, MD, Rohini Kelkar, MD, Tapan Saikia, MD, Sadhana Kannan, MSc, Navin Khattry, MD DM

Blood (2017) 130 (Supplement 1): 1945.

https://doi.org/10.1182/blood.V130.Suppl_1.1945.1945

Published: 2017

Journal Articles

Efficacy of Cidofovir in Treatment of BK Virus Induced Hemorrhagic Cystitis in Post Allogeneic Hematopoietic Cell Transplant Recipients

Eric Anthony Coomes, MD, Amanda Jacques, BScPharm, RPh, ACPR, Fotios V. Michelis, MD PhD, Dennis (Dong-Hwong) Kim, MD PhD, Santhosh Thyagu, MD, Auro Viswabandya, MDMDcine,DM Clinical Hematology, Jeff H. Lipton, MD PhD, Hans A. Messner, MD PhD, Uday Deotare, MD

Blood (2017) 130 (Supplement 1): 5479.

https://doi.org/10.1182/blood.V130.Suppl_1.5479.5479

Published: 2017

Journal Articles

Leflunomide Inhibits c-Myc Signaling and Impairs Myeloma Cell Growth

Ralf Buettner, PhD, Corey James Morales, BA, BS, Enrico Caserta, PhD, Domenico Viola, BS, Joycelynne M. Palmer, PhD, Xiwei Wu, PhD, Nagarajan Vaidehi, PhD, Hongzhi Li, PhD, Tim Synold, PhD, Amrita Krishnan, MD, Flavia Pichiorri, PhD, Michael Rosenzweig, MD, Steven T. Rosen, MD

Blood (2017) 130 (Supplement 1): 4426.

https://doi.org/10.1182/blood.V130.Suppl_1.4426.4426

Published: 2017

Journal Articles

Efficacy of Third Party BK Virus (BKV) Specific Cytotoxic T-Lymphocytes Generated By Ex Vivo Expansion for the Treatment of BKV Infection in Stem Cell Transplant Recipients, a Phase 2 Trial

Blood (2016) 128 (22): 504.

https://doi.org/10.1182/blood.V128.22.504.504

Published: 2016

Journal Articles

Repurposing Leflunomide for Multiple Myeloma Treatment

Ralf Buettner, PhD, Corey Morales, BA, BS, Natalie Perret, Joycelynne Palmer, PhD, Amrita Krishnan, Michael Rosenzweig, MD, Steven T. Rosen, MD

Blood (2016) 128 (22): 5667.

https://doi.org/10.1182/blood.V128.22.5667.5667

Published: 2016

Journal Articles

Myelodysplastic Syndromes and Acute Myelogenous Leukemia Resulting from Therapy for Autoimmune Disease, a Case-Control Cohort Study

Natalie Ertz-Archambault, MD, Heidi Kosiorek, M.S., Janna Castro, Gretchen Taylor, MD, Robert Marino, Amylou Constance Dueck, PhD, Aref Al-Kali, MD, Susanne Gauthier, R.N., Laura E. Finn, MD, James M. Foran, MD, Lisa Sproat, MD MSW, Raoul Tibes, MD PhD

Blood (2015) 126 (23): 5636.

https://doi.org/10.1182/blood.V126.23.5636.5636

Published: 2015

Journal Articles

BK Virus Disease Following Allogeneic Stem Cell Transplantation: A Cohort Analysis

Nienke MG Rorije, Margaret M Shea, Gowri Satyanarayana, MD, Sarah P Hammond, MD, Vincent T Ho, MD, Lindsey R Baden, MD, Joseph H Antin, MD, Robert J Soiffer, MD, Francisco M Marty, MD

Blood (2012) 120 (21): 1927.

https://doi.org/10.1182/blood.V120.21.1927.1927

Published: 2012

Journal Articles

Defining Treatment Paradigms for BK Virus-Induced Hemorrhagic Cystitis in the Post-Allogeneic Hematopoietic Stem Cell Transplant Setting

Devi D Morrison, Samith Thomas Kochuparambil, David Deremer, Ethan Speir, Kristen Sterling, Meghan Sterrett, Vamsi Kota, MBBS, Anand P. Jillella, MD, Farrukh T Awan, MD, MS

Blood (2011) 118 (21): 4468.

https://doi.org/10.1182/blood.V118.21.4468.4468

Published: 2011

Journal Articles

Favorable Results After GCSF-Primed Allogeneic BMT for Children with Severe Aplastic Anemia Using Busulfan, Cyclophosphamide and ATG as Conditioning Regimen and Cyclosporine-A and Micofenolate Mofetil as Graft-Versus-Host-Disease Prophylaxys: Rapid Engraftment, Low Incidence of Chronic Gvhd and Reduced Graft Rejection Rates.

Mauricio Ostronoff, MD, Fabiana Ostronoff, MD, Rodolfo Calixto, Alexandre Sucupira, Manuela Gomes, Rodrigo Florencio, MD, Monique Martins, ANA Patricia Souto Maior

Blood (2010) 116 (21): 3489.

https://doi.org/10.1182/blood.V116.21.3489.3489

Published: 2010

Journal Articles

G-CSF-Primed Allogeneic-BMT Following Reduced Intensity Conditioning (RIC) Regimen for Patients with AML. Rapid Engraftment, Low Incidence of Chronic Gvhd (cGVHD) and Good Outcome for Patients In 1 st Complete Remission (CR), but Not for More Advanced Cases

Mauricio Ostronoff, MD, ANA Patricia Souto Maior, Fabiana Ostronoff, MD, Rodrigo Florencio, MD, Monique Martins, Luis Fabio Botelho, Alexandre Sucupira, Mariana Coutinho, Rodolfo Calixto

Blood (2010) 116 (21): 3521.

https://doi.org/10.1182/blood.V116.21.3521.3521

Published: 2010

Journal Articles

Leflunomide Overcomes CD40L/IL-4-Mediated Resistance to Fludarabine-Induced Apoptosis and Effectively Blocks Proliferation of CLL Cells

Sascha Dietrich, Annika Zota, Michael Hess, Michael Rieger, Christof Schweizer, Anthony D. Ho, MD, FRCPC, Peter Dreger, MD, PhD, Thomas Luft

Blood (2010) 116 (21): 1388.

https://doi.org/10.1182/blood.V116.21.1388.1388

Published: 2010

Journal Articles

Alemtuzumab for Treatment of Acute Gvhd In Steroid-Refractory Patients .

Alexandre Sucupira, Mauricio Ostronoff, MD, Fabiana Ostronoff, MD, ANA Patricia Souto Maior, Jose Carlos Freitas, Rodrigo Florencio, MD, Luis Fabio Botelho, Monique Martins, Rodolfo Calixto

Blood (2010) 116 (21): 4545.

https://doi.org/10.1182/blood.V116.21.4545.4545

Published: 2010

Journal Articles

Favorable Resuls After Primed G-CSF BMT (G-BMT) for Patients (pts) with Severe Aplastic Anemia (SAA) Conditioning with Buslfan (Bu), Cyclophosphamide (Cy) and Rabbit ATG Using Mycophenolate Mofetil (MMF) and Cyclosporine-A (CSA) for Gvhd Prophylaxis: Rapid Neutrophil Engraftment, Low Rejection Rate and Chronic Gvhd .

Mauricio Ostronoff, MD, ANA Patricia Souto Maior, Rodolfo Calixto, Fabiana Ostronoff, MD, Rodrigo Florencio, MD, Monique Martins, Luis Fabio Botelho, Alexandre Sucupira, Mariana Coutinho

Blood (2010) 116 (21): 1279.

https://doi.org/10.1182/blood.V116.21.1279.1279

Published: 2010

Journal Articles

Levofloxacine Prophylaxis Decreases the Incidence of BK Polyoma Virus-Induced Hemorrhagic Cystitis in Patients after Allogeneic Hematopoietic Stem Cell Trans-Plantation

Yoko Ono, Manja Lache, Florian Jacob, Dominik Schneidawind, Anita Schmitt, Detlef Michel, Thomas Mertens, Hartmut Döhner, Donald Bunjes, Michael Schmitt

Blood (2008) 112 (11): 4343.

https://doi.org/10.1182/blood.V112.11.4343.4343

Published: 2008

Journal Articles

Unexpected Harmful Side Effects Triggered by Immune Modulation.

Marion Sternbach, MD, Alina Dragomir, MD, Mark A. Crowther, MD, Ann Holbrook, MD

Blood (2006) 108 (11): 4008.

https://doi.org/10.1182/blood.V108.11.4008.4008

Published: 2006

Journal Articles

Post-Engraftment Infections in Adult Patients Transplanted with Single Cord Blood Units Supported by Co-Infusion of Mobilized Purified Hematopoietic Stem Cells from a Third Party Donor.

J. Rafael Cabrera, Isabel Krsnik, Rafael Fores, Elena Ruiz, Guiomar Bautista, Belen Navarro, Jorge Gayoso, Santiago Gil, Carmen Regidor, Isabel Sanjuan, Emilio Ojeda, Jose A. Garcia-Marco, Manuel N. Fernandez

Blood (2005) 106 (11): 3240.

https://doi.org/10.1182/blood.V106.11.3240.3240

Published: 2005

NARROW

AG-636 for the Treatment of Adults with Advanced Lymphoma: Initiation of a Phase 1 Clinical Study

Transcriptional Regulation of Coenzyme Q Biosynthesis By TIF1γ Drives Erythropoiesis

Repurposing Leflunomide for Relapsed/Refractory Multiple Myeloma: Final Analysis of a Phase 1 Study

Repurposing Leflunomide for Relapsed/Refractory Multiple Myeloma: A Phase 1 Trial

Use of Leflunomide for Treatment of Cytomegalovirus Infection in Recipients of Allogeneic Stem Cell Transplant

Efficacy of Cidofovir in Treatment of BK Virus Induced Hemorrhagic Cystitis in Post Allogeneic Hematopoietic Cell Transplant Recipients

Leflunomide Inhibits c-Myc Signaling and Impairs Myeloma Cell Growth

Efficacy of Third Party BK Virus (BKV) Specific Cytotoxic T-Lymphocytes Generated By Ex Vivo Expansion for the Treatment of BKV Infection in Stem Cell Transplant Recipients, a Phase 2 Trial

Repurposing Leflunomide for Multiple Myeloma Treatment

Myelodysplastic Syndromes and Acute Myelogenous Leukemia Resulting from Therapy for Autoimmune Disease, a Case-Control Cohort Study

BK Virus Disease Following Allogeneic Stem Cell Transplantation: A Cohort Analysis

Defining Treatment Paradigms for BK Virus-Induced Hemorrhagic Cystitis in the Post-Allogeneic Hematopoietic Stem Cell Transplant Setting

G-CSF-Primed Allogeneic-BMT Following Reduced Intensity Conditioning (RIC) Regimen for Patients with AML. Rapid Engraftment, Low Incidence of Chronic Gvhd (cGVHD) and Good Outcome for Patients In 1 st Complete Remission (CR), but Not for More Advanced Cases

Leflunomide Overcomes CD40L/IL-4-Mediated Resistance to Fludarabine-Induced Apoptosis and Effectively Blocks Proliferation of CLL Cells

Alemtuzumab for Treatment of Acute Gvhd In Steroid-Refractory Patients .

Levofloxacine Prophylaxis Decreases the Incidence of BK Polyoma Virus-Induced Hemorrhagic Cystitis in Patients after Allogeneic Hematopoietic Stem Cell Trans-Plantation

Unexpected Harmful Side Effects Triggered by Immune Modulation.

Post-Engraftment Infections in Adult Patients Transplanted with Single Cord Blood Units Supported by Co-Infusion of Mobilized Purified Hematopoietic Stem Cells from a Third Party Donor.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only